Thymosin-α1

Thymosin-α1 decreases anti-S antibody waning in humans (β -0.123 (95% CI -0.212 to -0.034), p = 0.008).

“the durability of such response at both, the short-term and the long-term were predicted by the levels of thymosin-α1 [- 0.168 (- 0.305 to - 0.031); p = 0.017, and - 0.123 (- 0.212 to - 0.034); p = 0.008, respectively]”

Humans8 monthsmalesn = 98

Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home

Immunity & ageing : I & A·Mar 6, 2023